Sarepta治療 SRPT 深 滬
等待開盤 11-26 09:30:00 美东时间
19.35
+0.440
+2.33%
華盛通- 最 高19.45
- 今 開18.91
- 成交量 300.00万股
- 最 低 18.73
- 昨 收 18.91
- 總市值 18.91亿
- 52周最高 131.31
- 市盈率 靜 8.28
- 換手率 3.07%
- 52周最低 10.415
- 委 比 -4.44%
- 總股本 9771.34万
- 歷史最高 181.83
- 量 比 0.71
- 振 幅 3.81%
- 歷史最低 0.433
- 每 手 1
- 風險率 42.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk
FDA approves dosing in Sarepta's ENDEAVOR Cohort 8 to test sirolimus with Elevidys in non-ambulant Duchenne patients, targeting reduced liver injury.
今天 01:07
Arrowhead Pharmaceuticals Earns $200M Milestone Payment From Sarepta Therapeutics
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $200 million milestone payment from Sarepta Therapeutics (NASDAQ:SRPT). The milestone was earned when Arrowhead achieved the second
11-24 20:31
Tech Edges Up Ahead Of Nvidia's Earnings, Bitcoin Sinks Below $90,000: What's Moving Markets Wednesday?
All eyes are on Nvidia Corp. (NASDAQ:NVDA) as the world's most valuable company prepares to report third-quarter earnings after the close, a pivotal moment that could steer
11-20 01:45
Sarepta gene therapy Elevidys gets FDA Boxed Warning following two patient deaths
The US FDA has ordered a Boxed Warning be added to the labeling of Sarepta Therapeutics' (SRPT) Elevidys (delandistrogene moxeparvovec) about the risk of fatal acute liver failure for the gene therapy...
11-15 05:24
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
11-12 01:35
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
Sarepta raised to Outperform at Mizuho on strong results
Sarepta Therapeutics (SRPT) upgraded to Outperform from Neutral at Mizuho, citing stronger confidence in the commercial uptake of Elevidys following impressive third-quarter performance. The stock is ...
11-06 02:10
Why Is Dynatrace Stock Gaining Wednesday?
DT reported Q2 earnings that beat estimates, driven by demand for observability tools. ARR and subscription revenue rose.
11-05 21:44
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance
Sarepta's Duchenne trial missed its main goal but showed trends favoring treatment; Q3 earnings topped estimates amid Elevidys sales weakness.
11-05 01:33
